← Back
Scotts Miracle-Gro
SMG · listed on the New York Stock Exchange · worth $3.52 billion
$59.66
+0.51% on Oct 28
One insider buy in the last year, $49.5K in all. None in the last two weeks.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
44.6M shares
77% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Scotts Miracle-Gro stock and three insiders sold. None of the 5 sales is marked on its filing as planned in advance. The biggest seller was Hagedorn Partnership.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
EVP, CFO & CAO
Mark J. Scheiwer
Bought $49.5K on Feb 24 — 693 shares at $71.44, 4.5% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
Planned sales
Form 144 notices filed for Scotts Miracle-Gro in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Director Mark D. Kingdon filed to sell 831 shares on 10 Aug; sold 831 by 10 AugNotice on SEC.gov
10% holder Hagedorn Partnership filed to sell 30,000 shares on 3 Aug; sold 30,000 by 3 AugNotice on SEC.gov
Director Stephen L. Johnson filed to sell 1,171 shares on 30 Jul; sold 1,171 by 30 JulNotice on SEC.gov
Big investors
People and funds that reported owning 5% or more of Scotts Miracle-Gro, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateFMR LLC10.1%Oct 7Reported stake, oldest first: 7.0% (Aug 6) → 10.1% (Oct 7)Crossed 10%
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for Scotts Miracle-Gro.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
8 more with Pro →Analysts, earnings and news
Analysts' price target
$77.00 average
6 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q2 '26$2.82 a share+$0.30
Q1 '26$4.53 a share+$0.52
Q4 '25−$0.77 a share+$0.23
Q3 '25−$1.96 a share+$0.02